Literature DB >> 25808629

First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.

Carmela Nappi1, Michele Altiero, Massimo Imbriaco, Emanuele Nicolai, Caterina Anna Giudice, Marco Aiello, Claudio Tommaso Diomiaiuti, Antonio Pisani, Letizia Spinelli, Alberto Cuocolo.   

Abstract

PURPOSE: Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder associated with severe multiorgan dysfunction and premature death. Early diagnosis and treatment strategies play a key role in patient outcome. We investigated the potential role of hybrid PET/MR imaging in the assessment of early cardiac involvement in AFD patients.
METHODS: Thirteen AFD patients without cardiac symptoms and with normal left ventricular function underwent simultaneous cardiac PET/MR imaging after administration of (18)F-FDG. Cardiac FDG uptake was quantified by measuring the standardized uptake value in 17 myocardial segments in each subject. The coefficient of variation (COV, i.e. the standard deviation divided by the average) of the uptake of the 17 segments was calculated as an index of heterogeneity in the heart.
RESULTS: Six patients exhibited focal late gadolinium enhancement (LGE) indicating intramyocardial fibrosis, and four of these also had positive short inversion time inversion recovery (STIR) sequences. All patients with LGE and positive STIR MR images showed focal FDG uptake in the corresponding myocardial segments indicating inflammation. Of the seven patients with negative LGE and STIR images, five showed homogeneous FDG cardiac uptake and two showed heterogeneous FDG uptake. The COV was significantly greater in patients with focal FDG uptake (0.25 ± 0.02) than in those without (0.14 ± 0.07, p < 0.01).
CONCLUSION: PET/MR imaging is clinically feasible for the early detection of cardiac involvement in patients with AFD. Further studies evaluating the role of hybrid PET/MR imaging in management of the disease in larger patient populations are warranted.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808629     DOI: 10.1007/s00259-015-3036-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

1.  MRI characterization of myocardial tissue in patients with Fabry's disease.

Authors:  Massimo Imbriaco; Letizia Spinelli; Alberto Cuocolo; Simone Maurea; Giacomo Sica; Mario Quarantelli; Antonio Pisani; Raffaele Liuzzi; Bruno Cianciaruso; Massimo Sabbatini; Marco Salvatore
Journal:  AJR Am J Roentgenol       Date:  2007-03       Impact factor: 3.959

2.  Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.

Authors:  J vom Dahl; C Altehoefer; F H Sheehan; P Buechin; G Schulz; E R Schwarz; K C Koch; R Uebis; B J Messmer; U Buell; P Hanrath
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

Review 3.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

4.  Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.

Authors:  Eugenio Inglese; Lucia Leva; Roberta Matheoud; Gianmauro Sacchetti; Chiara Secco; Patrizia Gandolfo; Marco Brambilla; Gianmario Sambuceti
Journal:  J Nucl Med       Date:  2007-09-14       Impact factor: 10.057

5.  Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.

Authors:  Joanna Wykrzykowska; Sanaz Lehman; Gethin Williams; J Anthony Parker; Matthew R Palmer; Santosh Varkey; Gerald Kolodny; Roger Laham
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

6.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

Authors:  Gethin Williams; Gerald M Kolodny
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

7.  Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.

Authors:  Frank Weidemann; Markus Niemann; Frank Breunig; Sebastian Herrmann; Meinrad Beer; Stefan Störk; Wolfram Voelker; Georg Ertl; Christoph Wanner; Jörg Strotmann
Journal:  Circulation       Date:  2009-01-19       Impact factor: 29.690

8.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983

Review 9.  Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature.

Authors:  Antonio Pisani; Bianca Visciano; Graciana Diez Roux; Massimo Sabbatini; Caterina Porto; Giancarlo Parenti; Massimo Imbriaco
Journal:  Mol Genet Metab       Date:  2012-08-11       Impact factor: 4.797

Review 10.  Fibrosis: a key feature of Fabry disease with potential therapeutic implications.

Authors:  Frank Weidemann; Maria D Sanchez-Niño; Juan Politei; João-Paulo Oliveira; Christoph Wanner; David G Warnock; Alberto Ortiz
Journal:  Orphanet J Rare Dis       Date:  2013-08-06       Impact factor: 4.123

View more
  24 in total

1.  Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease.

Authors:  Massimo Imbriaco; Teresa Pellegrino; Valentina Piscopo; Mario Petretta; Andrea Ponsiglione; Carmela Nappi; Marta Puglia; Serena Dell'Aversana; Eleonora Riccio; Letizia Spinelli; Antonio Pisani; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-22       Impact factor: 9.236

2.  Time to move to PET-MR for cardiovascular imaging.

Authors:  Olivier Lairez; Philip M Robson; Zahi A Fayad
Journal:  J Nucl Cardiol       Date:  2015-07-02       Impact factor: 5.952

3.  Cardiac amyloidosis: A new challenge of multimodality imaging.

Authors:  Carmela Nappi; Roberta Assante; Emilia Zampella; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-06-26       Impact factor: 5.952

4.  Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET/MR imaging.

Authors:  Felix Nensa; E Tezgah; K Schweins; J Goebel; P Heusch; K Nassenstein; T Schlosser; T D Poeppel
Journal:  J Nucl Cardiol       Date:  2016-03-18       Impact factor: 5.952

Review 5.  Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature.

Authors:  Jeffrey M C Lau; Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2016-06

Review 6.  Positron emission tomography/MRI for cardiac diseases assessment.

Authors:  Osamu Manabe; Noriko Oyama-Manabe; Nagara Tamaki
Journal:  Br J Radiol       Date:  2020-02-14       Impact factor: 3.039

Review 7.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

8.  Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.

Authors:  Letizia Spinelli; Teresa Pellegrino; Antonio Pisani; Caterina Anna Giudice; Eleonora Riccio; Massimo Imbriaco; Marco Salvatore; Bruno Trimarco; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-07       Impact factor: 9.236

Review 9.  Fabry Disease and the Heart: A Comprehensive Review.

Authors:  Olga Azevedo; Filipa Cordeiro; Miguel Fernandes Gago; Gabriel Miltenberger-Miltenyi; Catarina Ferreira; Nuno Sousa; Damião Cunha
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 10.  Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future.

Authors:  Roberta Esposito; Ciro Santoro; Giulia Elena Mandoli; Vittoria Cuomo; Regina Sorrentino; Lucia La Mura; Maria Concetta Pastore; Francesco Bandera; Flavio D'Ascenzi; Alessandro Malagoli; Giovanni Benfari; Antonello D'Andrea; Matteo Cameli
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.